Stock Price
21.36
Daily Change
-0.42 -1.93%
Monthly
6.80%
Yearly
68.99%
Q2 Forecast
20.23



Peers Price Chg Day Year Date
Agrana Beteiligungs 11.85 0.20 1.72% -3.66% Jun/05
Austevoll Seafood 83.20 -0.30 -0.36% -13.06% Jun/05
British American Tobacco 4,404.00 84.00 1.94% 25.11% Jun/05
Beiersdorf 70.00 2.44 3.61% -41.54% Jun/05
Danone 64.42 0.76 1.19% -13.06% Jun/05
Givaudan 2,869.00 30.00 1.06% -31.27% Jun/05
Glanbia 21.36 -0.42 -1.93% 68.99% Jun/05
Henkel 67.10 1.74 2.66% -4.01% Jun/05
International Flavors Fragrances 73.01 -0.22 -0.30% -5.06% Jun/05
Imperial Brands 2,761.00 75.00 2.79% -4.00% Jun/05

Indexes Price Day Year Date
ISEQ 13113 -25.93 -0.20% 12.83% Jun/05
EU600 623 -1.79 -0.29% 12.47% Jun/05

Glanbia traded at 21.36 this Friday June 5th, decreasing 0.42 or 1.93 percent since the previous trading session. Looking back, over the last four weeks, Glanbia lost 6.80 percent. Over the last 12 months, its price rose by 68.99 percent. Looking ahead, we forecast Glanbia to be priced at 20.23 by the end of this quarter and at 18.44 in one year, according to Trading Economics global macro models projections and analysts expectations.

Glanbia plc is a global nutrition company. The Company operates through two segments: Glanbia Performance Nutrition and Glanbia Nutritionals. The Company's Glanbia Performance Nutrition segment includes performance nutrition products. Its products are sold through a range of channels, including specialty retail, the Internet and gyms in a range of formats, including powders, bars and ready-to-drink beverages. The Company's Glanbia Nutritionals segment provides nutritional solutions. It manufactures and sells cheese, dairy and non-dairy nutritional ingredients and vitamin and mineral premixes targeting the market focus on health and nutrition.